RUTW241202P2075000
- 0.00
- 0.000.00%
Russell 2000 Index Newsroom
REX American Resources Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results.
IAS Announces Plans To Expand Into China To Enable Global Advertisers With Invalid Traffic, Fraud, And Brand Safety And Suitability Measurement, Aligned To International And Local Standards
Unnatural Products Announces BridgeBio Exercises Option To License Macrocyclic Peptide Candidates Discovered Using UNP's AI-Enabled Massively Parallel Chemistry Platform
Looking Into Centrus Energy's Recent Short Interest
Piper Sandler Maintains Neutral on Fastly, Raises Price Target to $10
BGC Group Sells Capitalab for $46M to Focus on Fenics
US Morning News Call | Stock Futures Show Minimal Change as Investors Increase Wagers on December Rate Cut
This Citigroup Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
GrafTech International Analyst Ratings
Janux Therapeutics Shares Are Trading Higher After the Company Announced Updated Interim Clinical Data for Its JANX007 Program in Prostate Cancer.
Barclays Maintains Equal-Weight on PTC Therapeutics, Raises Price Target to $56
PTC Therapeutics Analyst Ratings
Follow Nvidia's Lead in Investing in Small-Cap AI Stocks
Takeda Tapped Keros Therapeutics Under A $200M Deal Along With Earn Out Of Over $1.1B To Boost Oncology Pipeline With Elritercept Beyond China, Hong Kong and Macau
Market-Moving News for December 3rd
A Closer Look at 4 Analyst Recommendations For Associated Banc
Mirion 2025 Outlook: Expects Organic Revenue Growth Of 5.5%-7.5%, Revenue Growth Of 4%-6%; And Adjusted Free Cash Flow Of $85M- $110M
Integer Holdings Analyst Ratings
Ocular Therapeutix Analyst Ratings
HC Wainwright & Co. Maintains Buy on Janux Therapeutics, Raises Price Target to $70